MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
This study is ongoing, but not recruiting participants.
Millennium Pharmaceuticals, Inc.
First Posted: March 24, 2010
Last Update Posted: February 10, 2017
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||August 2017|
|Primary Completion Date:||June 2015 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||February 8, 2017|